Integrating candidate MRs, genes negatively correlated with tumour cell MOMP activity, and CRISPR screening, FOXO1 emerged as the most significant MR associated with the maintenance of immunotherapy resistance (Figure 6D). Here, FOXO1 is linked to neoplasm.